Private equity firm Montagu entered into exclusive negotiations to sell French health supplement maker Arkopharma to branded drug manufacturer Dermapharm for EUR 450m.
Private equity firm Montagu entered into exclusive negotiations to sell French health supplement maker Arkopharma to branded drug manufacturer Dermapharm for EUR 450m.